Clinical Study
Hematopoietic Stem-Cell Transplantation in the Developing World: Experience from a Center in Western India
Table 1
Baseline patient characteristics and transplant data of our autologous and allogeneic patients.
| Characteristics | Autologous | Allogeneic |
| (1) Total numbers () | = 35 | = 15 |
| (2) Age (median) | 50 years | 21 years |
| (3) Gender (M : F) | 28 : 7 | 13 : 2 |
| (4) Indications | Multiple myeloma: 20 Non-Hodgkin lymphoma: 7 Hodgkin lymphoma: 5 Acute myeloid leukemia: 3 | Chronic myeloid leukemia: 3 Aplastic anemia: 3 Thalassemia major: 3 Acute lymphoblastic leukemia: 2 Acute myeloid leukemia: 2 Myelodysplastic syndrome: 1 Non-Hodgkin lymphoma: 1 |
| (5) Stem-cell source | All patients from peripheral blood | Peripheral blood: 11 Bone marrow: 4 |
| (6) Stem-cell dose (median cell dose) | 2.56∧106 cells | 5.15∧106 cells |
| (7) Donor type | Not applicable | All siblings |
| (8) HLA matching | Not applicable | 6/6 matched: = 14 4/6 matched: = 1 |
|
|